Is it time to bet on a turnaround?
Ambrx Biopharma Inc (NASDAQ: AMAM) announced preliminary safety and efficacy data from its Phase 2 ACE‑Breast-03 study. The data presented demonstrated a 51.7% overall response rate (ORR) and 100% disease control rate (DCR) after treatment with ARX788 in HER2-positive mBC patients who are resistant or refractory to T-DM1. ACE-Breast-03 is a Phase 2 study of ARX788 for patients whose metastatic disease is resistant or refractory to T-DXd, T-DM1, or tucatinib-containing regimens. Related: Ambrx Bi
Recession fears are in the air, and analysts are turning away from the oil and natural gas names that outperformed in 2022.
A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.
On Dec. 9, the leaders of Saudi Arabia and China met in Riyadh—Xi Jinping’s first visit there since 2016. He and his counterpart, crown prince Mohammed bin Salman, agreed meet more often and signed a number of deals broadly aimed at aligning the countries’ mid-term development agendas, China’s Belt and Road Initiative and Saudi’s Vision 2030.
Elon Musk has praised his competitors but never hidden his competitive edge. And he just tweeted out that edge in a big way.
If you're looking to generate passive income, AT&T's stock provides a healthy dividend payment.
(Bloomberg) -- Vanguard Group Inc.’s decision to leave the world’s largest climate-finance coalition was slammed by former US Vice President Al Gore, who said the move was out of step with the growing awareness among business leaders that they can no longer afford to ignore global warming.Most Read from BloombergPutin Calls Russian Nukes Deterrent Factor, Says War Risk RisingTesla's Troubles Are Piling Up While Elon Musk Is Distracted With TwitterWNBA Star Griner Freed in One-for-One Swap for Ar
The COVID pandemic is receding into the rear view mirror, and good riddance to it. It’s left a mark, though, and in areas as varied as education, employment, and e-commerce, we’ll be dealing with the repercussions for months, or even years, to come. For investors, the pandemic was the time to get into companies connected with online shopping, home digital entertainment, and wireless networking. With the lockdowns and work-from-home, these areas soared. But – they’ve seen sharp losses more recent
Kinder Morgan (NYSE: KMI) gave investors a glimpse into what they should expect in the coming year by unveiling its preliminary financial expectations for 2023. Management expects Kinder Morgan to generate $7.7 billion in adjusted EBITDA next year. Growth drivers include rising volumes at its refined product and gathering and processing businesses, higher rates as it recontracts its Jones Act tankers, and expansion projects coming into service.
With U.S. stocks down more than 20% so far this year, investors are looking for some good news – and it may be coming from a prominent Wall Street analyst who says the current bear market could come to an … Continue reading → The post Top Morgan Stanley Strategist Says This Is When the Bear Market ‘Will Be Over Probably' appeared first on SmartAsset Blog.
As mainland China backs away from its zero-COVID policy and loosens restrictions, business optimism and a slight return to normalcy are welcome changes for citizens and investors.
The initial spike in Tilray and other cannabis stocks came after reports surfaced that Senate Majority Leader Chuck Schumer hoped to pass two cannabis reform bills before the holiday break. Top Republicans, however, managed to prevent the marijuana reform provisions from being attached to the version that was finalized Tuesday night. Federal banking laws keep Canadian marijuana companies like Tilray from doing business even in U.S. states that have legalized pot.
Today's Research Daily features update on the Q4 earnings season and new research reports on Merck (MRK), Bristol-Myers (BMY) and Deere (DE).
Retirement-eligible salaried employees at Ford were warned about retiring this year to maximize a lump sum pension payment.
Nio (NYSE: NIO) pleased investors with its forward projections when it reported third-quarter earnings a month ago. When Nio announced its quarterly results on Nov. 10, it told investors vehicle deliveries increased almost 30% year over year. Today, Li Auto (NASDAQ: LI) said it also expects to deliver up to 48,000 EVs in its fourth quarter.
Finding the right stock is the key to successful investing, but it’s never as easy as that sounds. The answer to the question, which stock to buy? is no secret, but it is hidden, in the avalanche of data that the markets produce. What’s needed is some clear signal that will cut through the noise and indicate the right stocks for the times. The quantity of data, and the sheer impossibility of parsing all of it in real time, makes a formidable barrier to successful stock picking – but Wall Street’
Yahoo Finance Live anchors discuss the rise in stock for DocuSign following third-quarter earnings.
Tesla (NASDAQ: TSLA) investors have been having a rough week. Through close of trading Thursday, shares of the electric car stock leader fell 11% from last week's close, as multiple reports of production slowdowns in Shanghai dinged the stock -- but there's better news for Tesla today. As of 11:20 a.m. ET, Tesla stock is up 4.1%, despite more news of production slowdowns in China.
This high-profile mortgage REIT hasn't worked out as well as most dividend investors may have hoped over the past decade.